These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 23651030)

  • 1. Pharmacogenetics in clinical practice: how far have we come and where are we going?
    Johnson JA
    Pharmacogenomics; 2013 May; 14(7):835-43. PubMed ID: 23651030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of pharmacogenetics in cancer therapeutics.
    Yong WP; Innocenti F; Ratain MJ
    Br J Clin Pharmacol; 2006 Jul; 62(1):35-46. PubMed ID: 16842377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacogenomics: from bedside to clinical practice.
    Marsh S; McLeod HL
    Hum Mol Genet; 2006 Apr; 15 Spec No 1():R89-93. PubMed ID: 16651374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical implementation of pharmacogenetics.
    García-González X; Cabaleiro T; Herrero MJ; McLeod H; López-Fernández LA
    Drug Metab Pers Ther; 2016 Mar; 31(1):9-16. PubMed ID: 26751902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacogenomics in solid cancers and hematologic malignancies: Improving personalized drug prescription.
    Maillard M; Louveau B; Vilquin P; Goldwirt L; Thomas F; Mourah S
    Therapie; 2022; 77(2):171-183. PubMed ID: 34922740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advances and challenges in hereditary cancer pharmacogenetics.
    Cascorbi I; Werk AN
    Expert Opin Drug Metab Toxicol; 2017 Jan; 13(1):73-82. PubMed ID: 27603572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Developing pharmacogenetic evidence throughout clinical development.
    Burns DK
    Clin Pharmacol Ther; 2010 Dec; 88(6):867-70. PubMed ID: 20981004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacogenetics and pharmacogenomics in oncology therapeutic antibody development.
    Yan L; Beckman RA
    Biotechniques; 2005 Oct; 39(4):565-8. PubMed ID: 16235569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The medical and economic roles of pipeline pharmacogenetics: Alzheimer's disease as a model of efficacy and HLA-B(*)5701 as a model of safety.
    Roses AD
    Neuropsychopharmacology; 2009 Jan; 34(1):6-17. PubMed ID: 18923406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinically relevant cancer biomarkers and pharmacogenetic assays.
    Patel JN; Mandock K; McLeod HL
    J Oncol Pharm Pract; 2014 Feb; 20(1):65-72. PubMed ID: 23353710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacogenetics and pharmacogenomics as tools in cancer therapy.
    Rodríguez-Vicente AE; Lumbreras E; Hernández JM; Martín M; Calles A; Otín CL; Algarra SM; Páez D; Taron M
    Drug Metab Pers Ther; 2016 Mar; 31(1):25-34. PubMed ID: 26863347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Affymetrix DMET platform and pharmacogenetics in drug development.
    Deeken J
    Curr Opin Mol Ther; 2009 Jun; 11(3):260-8. PubMed ID: 19479659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Approaches to the discovery of pharmacogenomic markers in oncology: 2000-2010-2020.
    Huang RS; Dolan ME
    Pharmacogenomics; 2010 Apr; 11(4):471-4. PubMed ID: 20350124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Addressing the challenges of the clinical application of pharmacogenetic testing.
    Ikediobi ON; Shin J; Nussbaum RL; Phillips KA; ; Walsh JM; Ladabaum U; Marshall D
    Clin Pharmacol Ther; 2009 Jul; 86(1):28-31. PubMed ID: 19536122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Germline genetic testing to predict drug response and toxicity in oncology--reality or fiction?
    Soh TI; Yong WP
    Ann Acad Med Singap; 2011 Aug; 40(8):350-5. PubMed ID: 22065000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of drug metabolism enzyme and transporter pharmacogenetics in drug discovery and early development: perspectives of the I-PWG.
    Brian W; Tremaine LM; Arefayene M; de Kanter R; Evers R; Guo Y; Kalabus J; Lin W; Loi CM; Xiao G
    Pharmacogenomics; 2016 Apr; 17(6):615-31. PubMed ID: 27045656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytochrome P450 genotype-guided drug therapies: An update on current states.
    Dong AN; Tan BH; Pan Y; Ong CE
    Clin Exp Pharmacol Physiol; 2018 Oct; 45(10):991-1001. PubMed ID: 29858511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Moving Pharmacogenetics Into Practice: It's All About the Evidence!
    Luzum JA; Petry N; Taylor AK; Van Driest SL; Dunnenberger HM; Cavallari LH
    Clin Pharmacol Ther; 2021 Sep; 110(3):649-661. PubMed ID: 34101169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leveraging human genetics to develop future therapeutic strategies in rheumatoid arthritis.
    Plenge RM; Raychaudhuri S
    Rheum Dis Clin North Am; 2010 May; 36(2):259-70. PubMed ID: 20510233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacogenetics: from discovery to patient care.
    Shin J; Kayser SR; Langaee TY
    Am J Health Syst Pharm; 2009 Apr; 66(7):625-37. PubMed ID: 19299369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.